alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
---

EXHIBIT 13.B





CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with Amendment No. 2 to the
Annual Report of Petaquilla Minerals Ltd. (the Company) on Form 20-F for the fiscal period ended May 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Julie van Baarsen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| |    |  |                                                                                                                                                      
| | -- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------
| | 1. |  | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and    
| |    |  |                                                                                                                                                      
| | 2. |  | The information contained in the Report fairly presents, in all materials respects, the financial condition and results of operations of the Company.





|                              | 
|----------------------------- | 
|/s/ Julie van Baarsen         | 
|Julie van Baarsen            
|(principal financial officer)



Dated:  January 29, 2010





The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.





---
# C_2015089EN.01004602.xml

| 16.3.2015 | EN | Official Journal of the European Union | C 89/46 |
| --- | --- | --- | --- |

16.3.2015

EN

Official Journal of the European Union

C 89/46

---

Action brought on 24 December 2014 — ZZ v Commission

(Case F-141/14)

(2015/C 089/56)

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: L. Levi and A. Tymen, lawyers)

Applicant:

Defendant: European Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the decision rejecting the claim for damages brought by the applicant, who was the victim of a serious accident due to an administrative fault committed by the Commission, responsible for his medical file, and the claim for damages for the material and non-material damage allegedly suffered.

Form of order sought

Form of order sought

| — | Order the defendant to pay compensation for the applicant’s material and non-material damage; |
| --- | --- |

—

Order the defendant to pay compensation for the applicant’s material and non-material damage;

| — | in so far as it is necessary, annul the decision of 24 February 2014 rejecting his claim for damages of 15 November 2013; |
| --- | --- |

—

in so far as it is necessary, annul the decision of 24 February 2014 rejecting his claim for damages of 15 November 2013;

| — | in so far as it is necessary, annul the decision of 23 September 2014 rejecting his claim of 23 May 2014, supplemented by his note of 17 June 2014; |
| --- | --- |

—

in so far as it is necessary, annul the decision of 23 September 2014 rejecting his claim of 23 May 2014, supplemented by his note of 17 June 2014;

| — | order the defendant to pay all the costs. |
| --- | --- |

—

order the defendant to pay all the costs.

---
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 13-1002

TERRENCE ANTHONY WRAY,

Plaintiff - Appellant,

v.

PORTIA CATRELL WRAY,

Defendant - Appellee.

Appeal from the United States District Court for the District of 

South Carolina, at Florence. R. Bryan Harwell, District Judge. 

(4:11-cv-03443-RBH)

Submitted: April 25, 2013 Decided: April 29, 2013

Before AGEE and WYNN, Circuit Judges, and HAMILTON, Senior 

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Terrence Anthony Wray, Appellant Pro Se. Portia Catrell Wray, 

Appellee Pro Se.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Terrence Anthony Wray appeals the district court’s 

order dismissing his civil action for failure to prosecute. We 

have reviewed the record and find no reversible error. 

Accordingly, we grant leave to proceed in forma pauperis and

affirm for the reasons stated by the district court. Wray v. 

Wray, No. 4:11-cv-03443-RBH (D.S.C. Dec. 21, 2012). We dispense 

with oral argument because the facts and legal contentions are 

adequately presented in the materials before this court and 

argument would not aid the decisional process.

AFFIRMED
§ 810.17 Termination of a cease distribution and notification or mandatory recall order. ( a ) The person named in a cease distribution and notification order issued under § 810.10 or a mandatory recall order issued under § 810.13 may request termination of the order by submitting a written request to FDA. The person submitting a request shall certify that he or she has complied in full with all of the requirements of the order and shall include a copy of the most current status report submitted to the agency under § 810.16. A request for termination of a recall order shall include a description of the disposition of the recalled device.
( b ) FDA may terminate a cease distribution and notification order issued under § 810.10 or a mandatory recall order issued under § 810.13 when the agency determines that the person named in the order: ( 1 ) Has taken all reasonable efforts to ensure and to verify that all health professionals, device user facilities, consignees, and, where appropriate, individuals have been notified of the cease distribution and notification order, and to verify that they have been instructed to cease use of the device and to take other appropriate action; or
( 2 ) Has removed the device from the market or has corrected the device so that use of the device would not cause serious, adverse health consequences or death.
( c ) FDA will provide written notification to the person named in the order when a request for termination of a cease distribution and notification order or a mandatory recall order has been granted or denied. FDA will respond to a written request for termination of a cease distribution and notification or recall order within 30 working days of its receipt.
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF MARCH 31, 2000 AND FROM THE STATEMENT OF OPERATIONS FOR THE THREE
MONTHS ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         436,116
<SECURITIES>                                   0
<RECEIVABLES>                                  7,433
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0<F1>
<PP&E>                                         9,620,809
<DEPRECIATION>                                 0<F2>
<TOTAL-ASSETS>                                 10,201,919
<CURRENT-LIABILITIES>                          0<F1>
<BONDS>                                        4,792,688
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     5,233,889
<TOTAL-LIABILITY-AND-EQUITY>                   10,201,919
<SALES>                                        449,620
<TOTAL-REVENUES>                               461,295
<CGS>                                          0
<TOTAL-COSTS>                                  373,188
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             90,963
<INCOME-PRETAX>                                (2,856)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (2,856)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,856)
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0
<FN>
<F1>THE PARTNERSHIP HAS AN UNCLASSIFIED BALANCE SHEET, THEREFORE THE BALANCE IS
$0.
<F2>THIS INFORMATION IS NOT DISCLOSED IN THE PARTNERSHIP'S FORM 10-Q FILING.
</FN>


</TABLE>
### Geology and ground-water resources of western Sandoval County, New Mexico

By: B. Coleman Renick

                            https://doi.org/10.3133/wsp620

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               OCT-31-1999
<CASH>                                          28,538
<SECURITIES>                                         0
<RECEIVABLES>                                  662,753
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               692,491
<PP&E>                                       6,821,010
<DEPRECIATION>                             (1,800,164)
<TOTAL-ASSETS>                               5,918,457
<CURRENT-LIABILITIES>                        1,867,552
<BONDS>                                      3,571,273
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    24,169,536
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 5,918,457
<SALES>                                              0
<TOTAL-REVENUES>                             1,319,020
<CGS>                                                0
<TOTAL-COSTS>                                  603,891
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             136,589
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (864,435)
<EPS-BASIC>                                      (.14)
<EPS-DILUTED>                                    (.14)


</TABLE>
§ 529.1115 Halothane. ( a ) *Specifications.* The drug is a colorless, odorless, nonflammable, nonexplosive, heavy liquid containing 0.01 percent thymol as a preservative.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Two to 5 percent of inhaled atmosphere for induction of anesthesia; 0.5 to 2 percent for maintenance of anesthesia.
( 2 ) *Indications for use.* For nonfood animals for the induction and maintenance of anesthesia.
( 3 ) *Limitations.* Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[46 FR 27915, May 22, 1981, as amended at 62 FR 29014, May 29, 1997; 79 FR 10973, Feb. 27, 2014; 85 FR 4208, Jan. 24, 2020]
<PAGE>   1

                                   EXHIBIT 11

                    SUMMIT TECHNOLOGY, INC. AND SUBSIDIARIES
                 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
               (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS; UNAUDITED)

<TABLE>
<CAPTION>

                                                    THREE MONTHS              SIX MONTHS
                                                    ENDED JUNE 30,           ENDED JUNE 30,
                                                  1998         1997         1998        1997
==============================================================================================
<S>                                             <C>          <C>          <C>          <C>    

Net income                                      $30,504      $ 2,572      $30,681      $ 1,172
==============================================================================================
BASIC EARNINGS PER SHARE:

Weighted average common shares outstanding       31,277       31,158       31,178       31,020
                                                ----------------------------------------------

Net income per share                            $  0.98      $  0.08      $  0.98      $  0.04
==============================================================================================

DILUTED EARNINGS PER SHARE:

Weighted average common shares outstanding       31,277       31,158       31,178       31,020

Weighted average stock options outstanding           50          154           31          171
                                                ----------------------------------------------
Total weighted average                           31,327       31,312       31,209       31,191
                                                ----------------------------------------------

Net income per share                            $  0.97      $  0.08      $  0.98      $  0.04
==============================================================================================

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1995
<PERIOD-START>                              OCT-1-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                           1,103
<SECURITIES>                                         0
<RECEIVABLES>                                   31,105
<ALLOWANCES>                                   (1,299)
<INVENTORY>                                     19,729
<CURRENT-ASSETS>                                53,335
<PP&E>                                          83,634
<DEPRECIATION>                                (45,727)
<TOTAL-ASSETS>                                 111,559
<CURRENT-LIABILITIES>                           33,559
<BONDS>                                              0
<COMMON>                                        20,152
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      31,909
<TOTAL-LIABILITY-AND-EQUITY>                   111,559
<SALES>                                         39,133
<TOTAL-REVENUES>                                39,133
<CGS>                                           28,253
<TOTAL-COSTS>                                   28,253
<OTHER-EXPENSES>                                  (48)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 486
<INCOME-PRETAX>                                  1,391
<INCOME-TAX>                                       501
<INCOME-CONTINUING>                                890
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       890
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .15
        

</TABLE>
[Letterhead of Ballard, Spahr, Andrews and Ingersoll, LLP]

                                                                       Exhibit 8

                                                               December 27, 2001

Public Service Electric and Gas Company
80 Park Plaza
P.O. Box 570
Newark, NJ  07101

Ladies and Gentlemen:

      We have acted as special counsel to you (the "Company") in connection with
the  registration  of Trust  Preferred  Securities to be issued by PSE&G Capital
Trust III and  PSE&G  Capital  Trust IV,  and the  registration  of the  related
Guarantee  Agreement  and  Deferrable  Interest  Subordinated  Debentures of the
Company  and hereby  confirm to you our  opinion as set forth  under the heading
"United  States  Taxation"  in  the  Prospectus  included  in  the  Registration
Statement filed on Form S-3.

      We consent to the filing of this opinion as an exhibit to the Registration
Statement  and to the  reference to this firm under the heading  "United  States
Taxation" in the Prospectus included in the Registration Statement.

                                                   Very truly yours,

                                                   Ballard, Spahr, Andrews
                                                        and Ingersoll, LLP
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

                    The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y (12 CFR Part 225) to engage                     *de novo*, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States.                

                    Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Additional information on all bank holding companies may be obtained from the National Information Center website at                     *www.ffiec.gov/​nic/​*.                

Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than March 17, 2010.

**A. Federal Reserve Bank of Chicago**                     (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414:                

*1. Northwest Financial Corp.*, Arnolds Park, Iowa; to engage                     *de novo*                     through its subsidiary, Northwest Wealth Management, LLC, Arnolds Park, Iowa, in investment advisory and transactional activities, pursuant to sections 225.28(b)(6)(i); (b)(6)(ii); b)(6)(v); (b)(7)(i); (b)(7)(ii) and (b)(9)(ii), all of Regulation Y.                

Board of Governors of the Federal Reserve System, February 25, 2010.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. 2010-4226 Filed 3-1-10; 8:45 am]

BILLING CODE 6210-01-S
# C_2017022EN.01002101.xml

| 23.1.2017 | EN | Official Journal of the European Union | C 22/21 |
| --- | --- | --- | --- |

23.1.2017

EN

Official Journal of the European Union

C 22/21

---

Judgment of the General Court of 30 November 2016 — Bank Refah Kargaran v Council

(Case T-65/14) (1)

1

((Common Foreign and Security Policy - Restrictive measures against Iran - Freezing of funds - Further listing of the applicant after annulment of the initial listing by the General Court - Error in law - Error in fact - Obligation to state reasons - Rights of the defence - Right to effective judicial protection - Proportionality))

(2017/C 022/27)

Language of the case: French

Parties

Parties

Applicant: Bank Refah Kargaran (Teheran, Iran) (represented by: J.-M. Thouvenin, lawyer)

Applicant:

Defendant: Council of the European Union (represented by: V. Piessevaux, M. Bishop and B. Driessen, agents)

Defendant:

Intervener in support of the defendant: European Commission (represented by: A. Aresu and D. Gauci, agents)

Intervener in support of the defendant

Re:

Re:

Application based on Article 263 TFEU and seeking, principally, annulment of Council Decision 2013/661/CFSP of 15 November 2013 amending Decision 2010/413/CFSP concerning restrictive measures against Iran (OJ 2010 L 306, p. 18), and of Council Implementing Regulation (EU) No 1154/2013 of 15 November 2013, implementing Regulation (EU) No 267/2012 concerning restrictive measures against Iran (OJ 2013 L 306, p. 3), in so far as those acts concern the applicant, and, in the alternative, annulment of Decision 2013/661 and of Implementing Regulation No 1154/2013 in so far as those acts concern the applicant as from 20 January 2014.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Bank Refah Kargaran to pay, in addition to its own costs, the costs incurred by the Council of the European Union; |
| --- | --- |

2.

Orders Bank Refah Kargaran to pay, in addition to its own costs, the costs incurred by the Council of the European Union;

| 3. | Orders the European Commission to bear its own costs. |
| --- | --- |

3.

Orders the European Commission to bear its own costs.

---

(1)  OJ C 135, 5.5.2014.

1

---